Research Article

Chemometric Determination of Parkinson's Drugs Containing Multiple Active Substances

Volume: 45 Number: 1 March 28, 2024
EN

Chemometric Determination of Parkinson's Drugs Containing Multiple Active Substances

Abstract

In this work, the active ingredients of Entacapone, Levodopa and Carbidopa in drug samples used in the treatment of Parkinson's disease were quantitatively determined by Ultraviolet Visible (UV-VIS) Spectroscopy and chemometrics. Firstly, the spectra of each drug active ingredient were taken individually and then synthetic mixtures identical to the drug sample were analyzed. In our method, validation parameters were calculated for each method. Percent (%) recoveries were found on average for both the synthetic mixture and the commercial sample. The recoveries were quantitative for each method. The accuracy of the methods was tested by applying ANOVA test to the results obtained from the PLS and PCR calibration methods. The developed methods are reproducible, sensitive, and accurate, and can be recommended for the analysis of drug samples containing Entacapone, Levodopa, and Carbidopa

Keywords

References

  1. [1] Yalıman A., Şen E.İ., Parkinson Hastalığı ve Rehabilitasyonu, Türk Fiz Tıp Rehab. Derg., 57 (2011) 38-44.
  2. [2] Şahin A.R., Arık A.C., Depresyon ve Parkinson hastalığı, O.M.Ü. Tıp Dergisi, 11(3) (1994) 239-246.
  3. [3] Yiğit G., Arıcıoğlu F., Günümüz ve Gelecekte Parkinson Hastalığı için Farmakolojik Tedavi Yaklaşımları, MÜSBED, 5(4) (2015) 265-273.
  4. [4] Pekcan Ertokuş G., Özer T., Parkinson Hastalığının Tedavisinde Kullanılan Levodopa ve Benserazid Etken Maddelerinin Kemometrik Tayini, Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 13(2), (2020) 669-676.
  5. [5] Tashkhourian J., Hormozi-Nezhad M.R., Khodaveisi J., Application of silver nanoparticles and principal component-artificial neural network models for simultaneous determination of levodopa and benserazide hydrochloride by a kinetic spectrophotometric method, Spectrochimica acta. Part A, Molecular and Biomolecular Spectroscopy, 82(1) (2011) 25-30.
  6. [6] Damiani P.C., Moschetti A.C., Rovetto A.J., Benavente F., Olivieri A.C., Design and optimization of a chemometrics-assisted spectrophotometric method for the simultaneous determination of levodopa and carbidopa in pharmaceutical products, Analytica Chimica Acta, 543 (2005) 192–198.
  7. [7] Bugamelli F., Marcheselli C., Barba E., Raggi M.A., Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC–ED, Journal of Pharmaceutical and Biomedical Analysis, 54 (2011) 562-567.
  8. [8] Dinç E., Kemometri Çok Değişkenli Kalibrasyon Yöntemleri, Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi, 27(1) (2007) 61-92.

Details

Primary Language

English

Subjects

Analytical Chemistry (Other)

Journal Section

Research Article

Publication Date

March 28, 2024

Submission Date

August 29, 2023

Acceptance Date

January 2, 2024

Published in Issue

Year 2024 Volume: 45 Number: 1

APA
Arslan, A. M., & Pekcan, G. (2024). Chemometric Determination of Parkinson’s Drugs Containing Multiple Active Substances. Cumhuriyet Science Journal, 45(1), 47-53. https://doi.org/10.17776/csj.1351879

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December